FDA Approves First Insomnia Drug For Middle-of-the-Night Waking Followed By Difficulty Returning To Sleep

Links shared publicly online about this topic.

  • 0
    total visits

FDA Approves First Insomnia Drug For Middle-of-the-Night Waking Followed By Difficulty Returning To Sleep

medicalnewstoday.com

The U.S. Food and Drug Administration approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficu

View full resource at medicalnewstoday.com

Tags: Sleep Disorder, Sleep, Insomnia, Insomnia Medication, Diet and Nutrition, Drug, FDA

  • Share

Most Recently Shared on November 24, 2011 at 9:05 am By:

mnt_drugapprov MNT Drug Approvals

FDA Approves First Insomnia Drug For Middle-of-the-Night Waking Followed By Difficulty Returning To Sleep http://t.co/s994Smrr #regulatory

5 months ago...

Also Shared By:

MNT Sleep News MNT Sleep News

FDA approves first insomnia drug for middle-of-the-night waking followed by difficulty returning to sleep

fda.gov — “The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on November 23, 2011 at 6:12 pm By:

FiercePharma FiercePharma Health Site

RT @FDA_Drug_Info: FDA OKs 1st insomnia drug for middle-of-the-night waking w/difficulty returning to sleep http://t.co/byWbk6oI

5 months ago...

Advertisement